Corient Private Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.67M Sell
16,688
-785
-4% -$206K 0.01% 932
2026
Q1
$4.6M Sell
17,473
-13,545
-44% -$3.67M 0.01% 880
2025
Q4
$7.79M Buy
31,018
+4,031
+15% +$1.07M 0.01% 626
2025
Q3
$7.75M Buy
26,987
+1,986
+8% +$532K 0.01% 577
2025
Q2
$6.56M Buy
25,001
+306
+1% +$74.5K 0.01% 628
2025
Q1
$5.75M Sell
24,695
-8,188
-25% -$1.99M 0.01% 652
2024
Q4
$7.54M Sell
32,883
-959
-3% -$220K 0.01% 586
2024
Q3
$7.56M Buy
33,842
+6,437
+23% +$1.41M 0.01% 640
2024
Q2
$5.58M Sell
27,405
-11,751
-30% -$2.39M 0.01% 678
2024
Q1
$8.55M Sell
39,156
-653
-2% -$144K 0.02% 567
2023
Q4
$9.05M Sell
39,809
-240
-0.6% -$50.4K 0.02% 542
2023
Q3
$8.05M Buy
40,049
+17
+0% +$3.59K 0.02% 524
2023
Q2
$8.29M Sell
40,032
-167
-0.4% -$32.4K 0.02% 498
2023
Q1
$7.92M Buy
40,199
+25,536
+174% +$5.25M 0.02% 470
2022
Q4
$2.97M Buy
+14,663
New +$2.87M 0.01% 609

Other funds holding LH

Corient Private Wealth's LH Position: Q2 2026 in Review

Corient Private Wealth reduced its Labcorp (LH) stake by 4.5% in Q2 2026, selling an estimated $206K and leaving 16,688 shares worth $4.67M. The position accounts for 0.01% of the portfolio, ranked #932.

Corient Private Wealth first reported a position in LH in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.05M in Q4 2023. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Corient Private Wealth held 16,688 shares of Labcorp worth $4.67M as of Q2 2026.
  • Corient Private Wealth sold 785 Labcorp shares in Q2 2026, an estimated $206K.
  • Labcorp made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #932 holding.
  • Corient Private Wealth first reported a position in Labcorp in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Labcorp position peaked at $9.05M in Q4 2023.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.